Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/14/2012 | US8241909 Method for manufacturing glycoproteins having human-type glycosylation |
08/14/2012 | US8241899 Anti-TNF antibodies, compositions, methods and uses |
08/14/2012 | US8241896 Compositions for use in recombinational cloning of nucelic acids |
08/14/2012 | US8241888 microorganism capable of making an isoprenoid by changing the carbon flux through geranyl pyrophosphate, farnesyl pyrophosphate, or geranylgeranyl pyrophosphate and synthesis of isopentenyl pyrophosphate from an isoprenoid pathway; production of farnesol and geranylgeraniol |
08/14/2012 | US8241887 High density growth of T7 expression strains with auto-induction option |
08/14/2012 | US8241885 Engineered proteases for affinity purification and processing of fusion proteins |
08/14/2012 | US8241882 Hydrogen-producing bacterium, Clostridium perfringens |
08/14/2012 | US8241879 Biological methods for preparing adipic acid |
08/14/2012 | US8241877 Microorganisms for the production of methacrylic acid |
08/14/2012 | US8241871 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
08/14/2012 | US8241870 Mammalian expression vector with a highly efficient secretory signal sequence |
08/14/2012 | US8241855 Method for detecting cytosine methylations |
08/14/2012 | US8241854 Triggered RNAi |
08/14/2012 | US8241851 Methods for nucleic acid manipulation |
08/14/2012 | US8241849 Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2 |
08/14/2012 | US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
08/14/2012 | US8241845 Steroid 5α-reductase |
08/14/2012 | US8241642 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
08/14/2012 | US8241637 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof |
08/14/2012 | US8241628 Compositions and methods for antibodies targeting complement protein C5 |
08/14/2012 | US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same |
08/14/2012 | US8241624 Method of disinfecting packages with composition containing peracid and catalase |
08/14/2012 | US8241622 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences |
08/14/2012 | CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
08/14/2012 | CA2486345C Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
08/14/2012 | CA2458514C Modified cry3a toxins and nucleic acid sequences coding therefor |
08/14/2012 | CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity |
08/14/2012 | CA2449836C Stereoselective preparation of cyclic l-amino acids |
08/14/2012 | CA2449250C Regulation of lethal gene expression in plants |
08/14/2012 | CA2429954C Method for altering cell fate |
08/14/2012 | CA2408826C A method for generating hypermutable organisms |
08/14/2012 | CA2407905C Antibodies capable to selectively detect prion prpsc isoforms |
08/14/2012 | CA2404679C Adenine binding g-protein coupled receptors |
08/14/2012 | CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
08/14/2012 | CA2351396C Bioengineered tissue constructs and methods for producing and using them |
08/14/2012 | CA2283476C Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
08/14/2012 | CA2251544C Cystatin b mutants |
08/09/2012 | WO2012106615A1 Methods and materials for enhancing functional protein expression in bacteria |
08/09/2012 | WO2012106591A1 Synthetic mimics of mir-34 |
08/09/2012 | WO2012106586A1 Synthetic mimics of mir-124 |
08/09/2012 | WO2012106536A2 Systems, tip assemblies, methods and kits for introducing material into cells |
08/09/2012 | WO2012106490A1 Multivalent vaccines for rabies virus and filoviruses |
08/09/2012 | WO2012106353A2 Testosteronan, a novel heparosan analog, testosteronan synthase, and methods of production and use thereof |
08/09/2012 | WO2012106288A2 Methods of nucleic acid quantification and detection using anomalous migration |
08/09/2012 | WO2012106281A2 Multimodal trail molecules and uses in cellular therapies |
08/09/2012 | WO2012106257A1 Production of industrially relevant compounds in prokaryotic organisms |
08/09/2012 | WO2012106192A1 Antibody specific for sulfatase-2 and methods of use thereof |
08/09/2012 | WO2012106145A2 Compositions and methods for controlling carbon dioxide- (co2-) regulated stomatal apertures, water transpiration and water use efficiency in plants |
08/09/2012 | WO2012106072A2 Methods for minimizing sequence specific bias |
08/09/2012 | WO2012105853A1 Recombinant microorganisms with increased tolerance to ethanol |
08/09/2012 | WO2012105699A1 Method for production of antibody having high complement-dependent biological activity |
08/09/2012 | WO2012105696A1 Non-entomophilous tomato yellow leaf curl virus |
08/09/2012 | WO2012105630A1 Method for testing diseases associated with lipid metabolism, and method for assessment of prophylactic and/or therapeutic agent for diseases associated with lipid metabolism |
08/09/2012 | WO2012105616A1 Peptide library |
08/09/2012 | WO2012105596A1 Method for fluorescent labeling of protein |
08/09/2012 | WO2012105595A1 Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof |
08/09/2012 | WO2012105590A1 Determination marker for non-alcoholic steatohepatitis, and method for diagnosing non-alcoholic steatohepatitis using the marker as measure |
08/09/2012 | WO2012105565A1 Enzyme and method of production therefor |
08/09/2012 | WO2012105542A1 External preparation for skin |
08/09/2012 | WO2012105541A1 Novel japanese cypress pollen allergen |
08/09/2012 | WO2012105532A1 Novel use of maltotriosyl transferase |
08/09/2012 | WO2012105495A1 Phenylpyruvate reductase and method for manufacturing optically-active phenyllactic acid and 4-hydroxyl-phenyllactic acid using same enzyme |
08/09/2012 | WO2012104988A1 Enzyme and method of production therefor |
08/09/2012 | WO2012104987A1 Enzyme and method of production therefor |
08/09/2012 | WO2012104876A1 Virus resistant transgenic silkworm |
08/09/2012 | WO2012104843A1 Affinity maturated t cell receptors and use thereof |
08/09/2012 | WO2012104729A1 Modular dna-binding domains and methods of use |
08/09/2012 | WO2012104589A1 Weight related disorders |
08/09/2012 | WO2012104386A1 Antagonists of grasp55 for use as a medicament |
08/09/2012 | WO2012104059A2 Lentiviral vector comprising at least two tar elements |
08/09/2012 | WO2012103594A1 Barley with modified ssiii |
08/09/2012 | WO2012087903A3 Drought tolerant plants and related constructs and methods involving genes encoding mate-efflux polypeptides |
08/09/2012 | WO2012080550A3 Expression vectors for use in protein nanomechanics and use thereof in therapy and diagnosis |
08/09/2012 | WO2012079085A3 Structure, synthesis, and applications for conjugated polyampholytes |
08/09/2012 | WO2012078734A3 Polypeptide derived from calcitonin receptors and methods of use |
08/09/2012 | WO2012075150A3 Prediction of spontaneous preterm birth by measuring cell free nucleic acids in maternal blood |
08/09/2012 | WO2012074277A3 Novel hybrid promoter and recombinant vector comprising the same |
08/09/2012 | WO2012068107A3 Autoantibody to rna-protein complex detected by quantitative pcr |
08/09/2012 | WO2012067402A9 Red fluorescent protein fragment having a self-assembly activity, method for preparing same, and method for analyzing protein-protein interactions using same |
08/09/2012 | WO2012061726A3 Compositions and methods for sequencing dna |
08/09/2012 | WO2012053850A3 Detection of target nucleic acid sequences using dual-labeled immobilized probes on solid phase |
08/09/2012 | WO2012052995A3 Treatment and prevention of hepatocellular carcinoma with chemokine receptor modulators |
08/09/2012 | WO2012047015A9 Multiplex microfluidic device for selecting nucleic acid aptamers, and high throughput selection method for nucleic acid aptamers using same |
08/09/2012 | WO2012040323A8 Multimeric il-15 soluble fusion molecules and methods of making and using same |
08/09/2012 | WO2012021054A3 A diagnostic system for malaria |
08/09/2012 | WO2012015775A3 Sirna targeting vegfa and methods for treatment in vivo |
08/09/2012 | WO2012012689A3 Circulating micrornas are biomarkers of various diseases |
08/09/2012 | WO2011133559A3 Alpha tubulin acetyltransferase |
08/09/2012 | WO2011132939A8 Cytokine-bpb specifically binding to cytokine |
08/09/2012 | WO2011127340A3 Viral-based transient-expression vector system that allows multiple applications |
08/09/2012 | US20120204293 Glyphosate tolerant alfalfa events and methods for detection thereof |
08/09/2012 | US20120204292 Stress resistant plants |
08/09/2012 | US20120204291 Stress tolerant plants |
08/09/2012 | US20120204290 Agronomically elite lettuce with quantitative bremia lactuca resistance |
08/09/2012 | US20120204289 Manipulation of flavonoid biosynthetic pathway |
08/09/2012 | US20120204288 Drought tolerant plants and related constructs and methods involving genes encoding self-incompatibility protein related polypeptides |
08/09/2012 | US20120204287 Viral based transient-expression vector system that allows multiple applications |
08/09/2012 | US20120204286 Ho/ll canola with resistance to clubroot disease |
08/09/2012 | US20120204284 Tomato fruit having increased firmness |
08/09/2012 | US20120204281 Drg11-responsive (dragon) gene family |